BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

  January 15, 2026

   · 

  9 min read
• 

  Editorial

  JPM26: Verizon Outage Unites Directionless Conference Goers

  It doesn’t matter how many times you have traversed Union Square; no one knows which way is north, or where The Westin is in relation to the Ritz Carlton. A Verizon outage brought that into focus on Wednesday of JPM week.

  January 15, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Rare diseases

  JPM Day 3: Rare Disease in the Spotlight

  2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for this year.

  January 15, 2026

   · 

  5 min read

   · 

  Tristan Manalac
• 

  Legal

  Compounder Sues Lilly, Novo, Claims Coordinated Crackdown

  Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers in exclusive partnerships, disallowing them from offering compounded versions of GLP-1 medicines.

  January 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate

  Half of the net proceeds will go to Jazz; it remains unclear who will get the remaining sum. Jazz did not reveal the buyer of the voucher.

  January 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  FDA

  FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report

  Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite assurances of swift reviews under the FDA’s new Commissioner’s National Priority Voucher program.

  January 15, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

  Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET

  January 15, 2026

   · 

  5 min read
• Press Releases

  BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

  Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities

  January 15, 2026

   · 

  4 min read
• Press Releases

  Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.

  January 15, 2026

   · 

  5 min read
• Press Releases

  Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system

  Several recent steps move the closure toward commercialization: · New studies confirm the system’s usability and performance · Design now finalized and preparations for industrialization underway · Multiple new features set a new standard for luer lock closure systems

  January 15, 2026

   · 

  1 min read